Skip to main content
Premium Trial:

Request an Annual Quote

Discovery Partners Sells Over-Allotment on Sale of Celera Genomics Shares

NEW YORK, May 14 (GenomeWeb News) - Discovery Partners International announced today that it has taken in $5.1 million from an over-allotment option in a public offering of its common stock.


DPI said that 1,083,300 over-allotment shares were purchased at the price of $5 per share, following on a public offering of the 7,220,000 shares that Celera Genomics recently sold. The Applera unit announced on Wednesday that it had sold its DPI stock for $32 million.


SG Cowen was the lead manager and Merriman Curhan Ford and Roth Capital Partners were co-managers for the offering.


The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.